WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and CEO, Tod Woolf, Ph.D., will present a corporate overview at the 11th Annual BIO CEO and Investor Conference on Monday, February 9, 2009 at 10:30 a.m. ET, at the Waldorf-Astoria Hotel in New York City.
